Literature DB >> 2976426

The immune regulation in familial Mediterranean fever (FMF).

A Melamed1, S Cabili, V Zakuth, Z Spirer.   

Abstract

In order to investigate a possible immune regulation imbalance in familial Mediterranean fever (FMF), the T-cell subsets and interleukin (IL)-1 and -2 production were examined in 39 patients (32 consecutive; 7 previous) and 14 controls. Results in the FMF group indicated no change in total T-cells and B-cells. The number of supp T-cells and helper cells were significantly decreased, as compared to the controls (14 +/- 5.2, 19 +/- 4.6 vs. 31 +/- 4.6, 41 +/- 5.3, respectively), and the NK cells were significantly increased (16 +/- 4.8, 36 +/- 2.1). Peripheral blood monocytes from the patients with FMF produced higher amounts of IL-1 and lower amounts of IL-2 than those from the control subjects. The latter results were enhanced when the FMF group was subdivided on the basis of pretreatment with colchicine and presence of amyloidosis. This study, although preliminary, indicates an immune regulation imbalance in FMF patients. Further research is necessary to understand the interrelation of amyloidosis and colchicine treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2976426

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  8 in total

1.  Recurrent hereditary polyserositis.

Authors:  G C Cook
Journal:  BMJ       Date:  1990-11-17

2.  Serum soluble interleukin-2 receptor levels in familial Mediterranean fever.

Authors:  E Erken; R Güneşaçar; S Ozbek; K Konca
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

Review 3.  Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.

Authors:  Ilan Ben-Zvi; Avi Livneh
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

4.  Continuity of cytokine activation in patients with familial Mediterranean fever.

Authors:  Sait Bagci; Bulent Toy; Ahmet Tuzun; Yuksel Ates; Murat Aslan; Ali Inal; Mustafa Gulsen; Necmettin Karaeren; Kemal Dagalp
Journal:  Clin Rheumatol       Date:  2004-05-01       Impact factor: 2.980

5.  Does immune activation continue during an attack-free period in familial Mediterranean fever?

Authors:  U Musabak; A Sengul; C Oktenli; S Pay; Z Yesilova; L Kenar; S Y Sanisoglu; A Inal; A Tuzun; A Erdil; S Bagci
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

6.  Assessment of Circulating Microribonucleic Acids in Patients With Familial Mediterranean Fever.

Authors:  Ferhat Demİr; Alper Han Çebİ; Mukaddes Kalyoncu
Journal:  Arch Rheumatol       Date:  2019-11-06       Impact factor: 1.472

7.  Melatonin and its day and night rhythm of alterations in familial mediterranean Fever: a brief research letter.

Authors:  Ugur Musabak; Guldem Kilciler; Ahmet Uygun; Murat Kantarcıoglu; Zulfukar Polat; Rahsan I Sagkan; Sait Bagci
Journal:  Open Rheumatol J       Date:  2011-02-04

Review 8.  Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.

Authors:  Jessica Vandenhaute; Carine H Wouters; Patrick Matthys
Journal:  Front Immunol       Date:  2020-01-15       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.